Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Current Assets (2016 - 2025)

Historic Current Assets for Gyre Therapeutics (GYRE) over the last 17 years, with Q3 2025 value amounting to $98.6 million.

  • Gyre Therapeutics' Current Assets rose 7985.37% to $98.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.6 million, marking a year-over-year increase of 7985.37%. This contributed to the annual value of $64.8 million for FY2024, which is 1322.07% up from last year.
  • Per Gyre Therapeutics' latest filing, its Current Assets stood at $98.6 million for Q3 2025, which was up 7985.37% from $91.3 million recorded in Q2 2025.
  • In the past 5 years, Gyre Therapeutics' Current Assets registered a high of $116.5 million during Q1 2021, and its lowest value of $5.1 million during Q3 2023.
  • In the last 5 years, Gyre Therapeutics' Current Assets had a median value of $57.2 million in 2023 and averaged $58.7 million.
  • In the last 5 years, Gyre Therapeutics' Current Assets crashed by 9062.82% in 2023 and then skyrocketed by 96798.52% in 2024.
  • Quarter analysis of 5 years shows Gyre Therapeutics' Current Assets stood at $51.5 million in 2021, then fell by 3.54% to $49.7 million in 2022, then grew by 15.24% to $57.2 million in 2023, then increased by 13.22% to $64.8 million in 2024, then skyrocketed by 52.16% to $98.6 million in 2025.
  • Its last three reported values are $98.6 million in Q3 2025, $91.3 million for Q2 2025, and $68.4 million during Q1 2025.